Janssen PA - Search Results

1

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.

De Clerck F, Beetens J, de Chaffoy de Courcelles D, Vercammen E, Freyne E, Janssen PA. De Clerck F, et al. Among authors: janssen pa. Prog Clin Biol Res. 1989;301:567-72. Prog Clin Biol Res. 1989. PMID: 2529556 No abstract available.

2

5-Hydroxytryptamine and thromboxane A2 in ischaemic heart disease.

De Clerck F, Janssen PA. De Clerck F, et al. Among authors: janssen pa. Blood Coagul Fibrinolysis. 1990 Jun;1(2):201-9. Blood Coagul Fibrinolysis. 1990. PMID: 2130932 Review.

3

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.

De Clerck F, Beetens J, Van de Water A, Vercammen E, Janssen PA. De Clerck F, et al. Among authors: janssen pa. Thromb Haemost. 1989 Feb 28;61(1):43-9. Thromb Haemost. 1989. PMID: 2526385

4

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.

De Clerck F, Beetens J, de Chaffoy de Courcelles D, Freyne E, Janssen PA. De Clerck F, et al. Among authors: janssen pa. Thromb Haemost. 1989 Feb 28;61(1):35-42. Thromb Haemost. 1989. PMID: 2546278

5

5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.

De Clerck F, Loots W, Somers Y, Beetens J, Wouters L, Wynants J, Janssen PA. De Clerck F, et al. Among authors: janssen pa. Br J Pharmacol. 1990 Apr;99(4):631-6. doi: 10.1111/j.1476-5381.1990.tb12982.x. Br J Pharmacol. 1990. PMID: 2113823 Free PMC article.

6

Amplification mechanisms in platelet activation and arterial thrombosis.

De Clerck FF, Janssen PA. De Clerck FF, et al. Among authors: janssen pa. J Hypertens Suppl. 1990 Dec;8(7):S87-93. J Hypertens Suppl. 1990. PMID: 2128890 Review.

7

Arachidonic acid metabolites, ADP and thrombin modulate occlusive thrombus formation over extensive arterial injury in the rat.

De Clerck F, Van Gorp L, Beetens J, Verheyen A, Janssen PA. De Clerck F, et al. Among authors: janssen pa. Blood Coagul Fibrinolysis. 1990 Aug;1(3):247-58. doi: 10.1097/00001721-199008000-00001. Blood Coagul Fibrinolysis. 1990. PMID: 2151728

8

Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.

Van de Water A, d'Aubioul J, Van Gerven W, de Chaffoy de Courcelles D, Freyne E, Xhonneux R, Reneman RS, Janssen PA. Van de Water A, et al. Among authors: janssen pa. Arch Int Pharmacodyn Ther. 1992 Mar-Apr;316:60-74. Arch Int Pharmacodyn Ther. 1992. PMID: 1530374

9

Differential effects of verapamil and flunarizine on epinephrine-induced vasoconstriction and on spontaneous vasomotion of arterioles in skeletal muscle in the rat in vivo.

De Clerck F, Loots W, Voeten J, Janssen PA. De Clerck F, et al. Among authors: janssen pa. J Cardiovasc Pharmacol. 1989 Jan;13(1):76-83. J Cardiovasc Pharmacol. 1989. PMID: 2468939

10

Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.

de Cheffoy de Courcelles D, de Loore K, Freyne E, Janssen PA. de Cheffoy de Courcelles D, et al. Among authors: janssen pa. J Pharmacol Exp Ther. 1992 Oct;263(1):6-14. J Pharmacol Exp Ther. 1992. PMID: 1328613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters